See every side of every news story
Get Started
SubscribeLogin
Israel-Hamas Conflict
Tariffs
Liberation Day
Trade War
Natural Disasters
Social Media
Donald Trump
Stock Markets
Recession
Artificial Intelligence
Trade
Taxes
US Economy
Published • loading... • Updated

#Zevra Therapeutics? Bold Move: Cashing in $150 Million from Rare Disease Voucher Sale!,

Summary by csimarket.com
Zevra Therapeutics Enters Agreement to Sell its Rare Pediatric Disease Priority Review Voucher for $150 Million: Strategic Moves in a Dynamic Market Celebration, Fla. Feb. 27, 2025 ' Zevra Therapeutics, Inc. (NasdaqGS: ZVRA), a prominent player in the pharmaceutical industry dedicated to developing therapies for individuals with rare diseases, has made waves in the market with the announcement of a definitive asset purchase agreement regarding i…
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

2 Articles

All
Left
Center
Right
csimarket.comcsimarket.com

#Zevra Therapeutics? Bold Move: Cashing in $150 Million from Rare Disease Voucher Sale!,

Zevra Therapeutics Enters Agreement to Sell its Rare Pediatric Disease Priority Review Voucher for $150 Million: Strategic Moves in a Dynamic Market Celebration, Fla. Feb. 27, 2025 ' Zevra Therapeutics, Inc. (NasdaqGS: ZVRA), a prominent player in the pharmaceutical industry dedicated to developing therapies for individuals with rare diseases, has made waves in the market with the announcement of a definitive asset purchase agreement regarding i…

Read Full Article
pharmaceutical-technology.compharmaceutical-technology.com

Zevra sells priority review voucher for $150m to support drug launches - Pharmaceutical Technology

Zevra will use the $150m to support the commercial launches of rare disease drugs Miplyffa and Olpruva.

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

pharmaceutical-technology.com broke the news in on Thursday, February 27, 2025.
Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

Celebration

Celebration

You have read out of your 5 free daily articles.

Join us as a member to unlock exclusive access to diverse content.

News
For You
SearchBlindspotLocal